Activiomics

London, United Kingdom Founded: 2009 • Age: 17 yrs Acquired By hVIVO
Phosphoproteomic solutions are offered for biomarker discovery and drug development.
Request Access

About Activiomics

Activiomics is a company based in London (United Kingdom) founded in 2009 was acquired by hVIVO in March 2014.. Activiomics has raised $805 thousand across 1 funding round from investors including hVIVO and IP Group. Activiomics operates in a competitive market with competitors including Metabolon, Somalogic, Cyrus Biotechnology, Maze Therapeutics and Vividion Therapeutics, among others.

  • Headquarter London, United Kingdom
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Activiomics Limited
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $805 K (USD)

    in 1 rounds

  • Latest Funding Round
    $805 K (USD), Seed

    Mar 15, 2011

  • Investors
    hVIVO

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    hVIVO

    (Mar 03, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Activiomics

Activiomics has successfully raised a total of $805K through 1 strategic funding round. The most recent funding activity was a Seed round of $805 thousand completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $805,000
  • First Round

    (15 Mar 2011)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2011 Amount Seed - Activiomics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Activiomics

Activiomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include hVIVO and IP Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital and advisory services are offered across multiple sectors.
Founded Year Domain Location
Provider of cell based assays, field trial, and molecular services for biopharma sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Activiomics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Activiomics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Activiomics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Activiomics

Activiomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Somalogic, Cyrus Biotechnology, Maze Therapeutics and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Solutions for biomarker discovery and diagnostic testing are provided.
domain founded_year HQ Location
Protein-based assays are developed for life science research.
domain founded_year HQ Location
Cloud-based protein-modeling software is developed for drug discovery.
domain founded_year HQ Location
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Activiomics

Frequently Asked Questions about Activiomics

When was Activiomics founded?

Activiomics was founded in 2009 and raised its 1st funding round 2 years after it was founded.

Where is Activiomics located?

Activiomics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Is Activiomics a funded company?

Activiomics is a funded company, having raised a total of $805K across 1 funding round to date. The company's 1st funding round was a Seed of $805K, raised on Mar 15, 2011.

What does Activiomics do?

Activiomics was founded in 2009 in London, United Kingdom, focusing on the biotechnology sector. Phosphoproteomic technologies are utilized by the company for biomarker identification and drug development support. The TIQAS platform is employed to quantify phosphopeptides, with cell tissues broken down via protease into fragments and analyzed through mass spectrometry. Acquisition by Retroscreen (now hVivo) occurred in March 2014 for 4 million GBP.

Who are the top competitors of Activiomics?

Activiomics's top competitors include Alector, Somalogic and Maze Therapeutics.

Who are Activiomics's investors?

Activiomics has 2 investors. Key investors include hVIVO, and IP Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available